What: A combination of partnering and exhibition, ATW (or “Phacilitate” to the industry veterans) is an event that highlights the latest in cell and gene therapy business and market trends. This is not a technical forum but rather provides a broad overview of the CGT industry while affording good networking opportunities.

What: A Japan-focused event for peptide and oligonucleotide-based therapeutics that still brings a global flavor. More recently, mRNA and gene- editing content has also been included. A scientific program including posters and oral presentations, with topics ranging from discovery to R&D to CMC and commercialization. A small but growing exhibition for peptide/oligo/mRNA tools and service providers reflects the emergence of oligos and mRNA in Japan and throughout Asia.

What: An impressive event hosted by the nonprofit American Society of Gene And Cell Therapies, the annual meeting comprised of workshops, tools + technology forums, oral presentations, industry-sponsored symposia, posters, and an exhibition for tools and service providers. While focused on its US membership, there is still an international presence at this meeting with a mix of industry, academia, and patient advocates.

What: The so-called “largest event dedicated to peptide and oligonucleotide- based therapeutics,” TIDES USA is a renowned global event for oligos and peptides. More recently, mRNA and gene- editing content has also been included. A strong scientific program including posters and high-profile oral presentations, with topics ranging from discovery to R&D to CMC and commercialization. An impressive exhibition landscape for peptide/oligo/ mRNA tools and service providers. Highly recommended if you wish to learn about this space.

What: The International Society of Cell and Gene Therapies is a global society of clinicians, regulators, researchers, technologists, and industry partners with a shared vision to translate cell and gene therapy into safe and effective therapies to improve patients’ lives worldwide. This year’s annual meeting includes presentation tracks on basic and discovery research, bioprocessing & manufacturing, regulation & policy, therapeutic development, and tools & tech. An exhibition for tools and service providers is accompanied by a dedicated Innovation Zone for emerging and early-stage CGT developers and tools providers and includes a unique “pitch session” aimed at strategic partners and investors.

What: The largest and most comprehensive event for biotechnology, with over 20,000 participants from round the world. A massive exhibition with a very broad audience – much more business- oriented than technical. Expect business development and corporate types more than research scientists and process engineers – but good for networking in that regard.

What: A twofer: “BPI” is the original bioprocessing event which covers development and manufacturing of biologics and is co-located with the CGT Manufacturing & Commercialization which specifically covers cell and gene therapies. The scientific programs include posters and multiple streams of oral presentations, with topics ranging from discovery to R&D to CMC and commercialization. The joint exhibition includes both bioprocessing and CGT tools and service providers.

What: One of the best, if not the best, partnering meeting for cell and gene therapies. Not an expo, and not a scientific symposium, Meeting on Mesa is primarily for business partnering in the CGT space. Topics include technical trends in CGT development, clinical trial design, manufacturing, supply chain, and reimbursement models for advanced therapies. If your needs include licensing partners, venture capital investment, marketing collaborations, or good old- fashioned networking in CGT, Mesa is the place to be.